BOC Sciences

BOC Sciences launched inhibitors in accordance with Research areas. At present, there are three domains covered-cancer Immunotherapy, hsp90, alzheimer's disease.

BOC Sciences released an inhibitor BF 2649 also called ciproxidine last week. It's not the first time that the company provides the chemical, and in fact, the company supply it all the time.

BOC Sciences add a batch of inhibitors to its featured products line.

BOC Sciences has devoted a lot of effort in reorganizing its inhibitor products and make them an individual branch of the inhibitors they provide.

BOC Sciences recently announced that industrial scale chiral synthesis was available in their services range, which means that a new era for its chiral synthesis business will come.